Market Tracker

09/18 6:05pm ET

Echo Therapeutics Inc (NASDAQ:ECTE)

0.9699
Data as of Sep 18
 -0.66 / -40.50%
Today’s Change
0.72
Today|||52-Week Range
4.91
-69.11%
Year-to-Date

Today’s Trading

Previous close1.63
Today’s open1.62
Day’s range0.72 - 1.62
Volume764,710
Average volume (3 months)47,880
Market cap$20.7M
Dividend yield--
Data as of 3:59pm ET, 09/18/2014

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+59.66%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book0.99

Competitors

 Today’s
change
Today’s
% change
BGMDBG Medicine Inc-0.05-8.31%
RCHARich Pharmaceuticals...+0.00+4.17%
NVGNNovogen Ltd-0.16-5.16%
DARADARA BioSciences Inc-0.02-1.77%
Data as of 3:59pm ET, 09/18/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO, Secretary, Chief Compliance Officer &
SVP
Kimberly A. Burke
Senior Vice President-
Operations
Marshall D. Deweese
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts